Metraipolis › archive › dc_4a2da29c831f

Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy — Europe PMC PMID:42797334

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42797334
DOI
10.3390/pharmaceutics18091159
License (as archived)
solo-consultazione
Archived
2026-10-15T13:50:20.801Z
SHA-256 of the archived text
673610d8d77e991313c7807c580c1152f236e125b940a7e7b85e605b03c1ca24
Stable URL of this page
https://metraipolis.com/documento/dc_4a2da29c831f

How to cite

Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy — Europe PMC PMID:42797334 — Europe PMC (en), https://europepmc.org/article/MED/42797334 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a2da29c831f (Metraipolis archive dc_4a2da29c831f, sha256 673610d8d77e991313c7807c580c1152f236e125b940a7e7b85e605b03c1ca24)
BibTeX
@misc{dc4a2da29c831f,
  title = {Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy — Europe PMC PMID:42797334},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797334},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a2da29c831f; sha256 673610d8d77e991313c7807c580c1152f236e125b940a7e7b85e605b03c1ca24},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797334. Agents can read the archived copy with the MCP tool read_document.